Zentalis Pharmaceuticals Inc
NASDAQ:ZNTL
Zentalis Pharmaceuticals Inc
NASDAQ:ZNTL
Price:
2.71
USD
-1.45%
Market Closed
Market Cap:
$195.8m
Cash Flow Statement
Cash Flow Statement
Zentalis Pharmaceuticals Inc
Zentalis Pharmaceuticals Inc
Currency: USD
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Net Income |
(70)
|
(119)
|
(153)
|
(181)
|
(156)
|
(166)
|
(175)
|
(188)
|
(232)
|
(237)
|
(241)
|
(285)
|
(286)
|
(292)
|
(219)
|
(195)
|
(179)
|
(166)
|
(224)
|
(163)
|
(149)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
15
|
23
|
33
|
35
|
35
|
36
|
36
|
43
|
46
|
47
|
50
|
47
|
51
|
55
|
54
|
53
|
50
|
67
|
61
|
55
|
49
|
|
| Other Non-Cash Items |
15
|
24
|
33
|
36
|
(7)
|
(5)
|
(3)
|
9
|
56
|
59
|
65
|
82
|
82
|
78
|
14
|
14
|
5
|
10
|
70
|
31
|
29
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
4
|
8
|
12
|
13
|
19
|
17
|
10
|
15
|
12
|
13
|
13
|
4
|
(0)
|
6
|
(6)
|
13
|
1
|
(17)
|
1
|
(21)
|
(15)
|
|
| Cash from Operating Activities |
(50)
N/A
|
(87)
-72%
|
(107)
-24%
|
(132)
-22%
|
(144)
-10%
|
(154)
-7%
|
(167)
-8%
|
(164)
+2%
|
(163)
+0%
|
(164)
0%
|
(163)
+1%
|
(199)
-22%
|
(205)
-3%
|
(208)
-2%
|
(211)
-1%
|
(166)
+21%
|
(172)
-3%
|
(171)
+0%
|
(152)
+11%
|
(151)
+0%
|
(134)
+11%
|
|
| Investing Cash Flow | ||||||||||||||||||||||
| Capital Expenditures |
(0)
|
(1)
|
(1)
|
(2)
|
(5)
|
(6)
|
(6)
|
(6)
|
(5)
|
(3)
|
0
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Other Items |
(275)
|
(284)
|
(270)
|
(66)
|
(66)
|
(12)
|
(6)
|
(215)
|
(54)
|
(112)
|
(90)
|
125
|
(14)
|
(44)
|
(24)
|
(63)
|
102
|
177
|
156
|
152
|
132
|
|
| Cash from Investing Activities |
(275)
N/A
|
(285)
-4%
|
(271)
+5%
|
(67)
+75%
|
(71)
-5%
|
(18)
+74%
|
(12)
+35%
|
(220)
-1 772%
|
(59)
+73%
|
(114)
-93%
|
(92)
+20%
|
123
N/A
|
(14)
N/A
|
(44)
-211%
|
(25)
+44%
|
(64)
-154%
|
102
N/A
|
177
+73%
|
156
-12%
|
152
-3%
|
132
-13%
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Common Stock |
343
|
342
|
328
|
155
|
166
|
180
|
181
|
390
|
225
|
261
|
260
|
287
|
287
|
237
|
237
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
18
|
18
|
19
|
(0)
|
0
|
(1)
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
361
N/A
|
360
0%
|
347
-4%
|
155
-55%
|
166
+7%
|
179
+8%
|
180
+1%
|
390
+117%
|
224
-43%
|
261
+17%
|
260
0%
|
287
+10%
|
287
0%
|
237
-17%
|
237
0%
|
0
-100%
|
0
-67%
|
0
-2%
|
0
+170%
|
0
-4%
|
0
+9%
|
|
| Change in Cash | ||||||||||||||||||||||
| Net Change in Cash |
35
N/A
|
(11)
N/A
|
(32)
-183%
|
(44)
-38%
|
(50)
-13%
|
6
N/A
|
1
-81%
|
5
+353%
|
1
-79%
|
(17)
N/A
|
5
N/A
|
211
+3 772%
|
68
-68%
|
(15)
N/A
|
1
N/A
|
(229)
N/A
|
(70)
+70%
|
6
N/A
|
5
-22%
|
1
-83%
|
(2)
N/A
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
(51)
N/A
|
(88)
-73%
|
(109)
-24%
|
(133)
-23%
|
(149)
-12%
|
(160)
-8%
|
(173)
-8%
|
(169)
+2%
|
(168)
+1%
|
(166)
+1%
|
(163)
+2%
|
(201)
-24%
|
(205)
-2%
|
(208)
-2%
|
(211)
-1%
|
(167)
+21%
|
(172)
-3%
|
(171)
+1%
|
(152)
+11%
|
(151)
+0%
|
(134)
+11%
|
|
Switch to:
Switch to:
See Also
Discover More
